세계의 디지털 PCR 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

Digital PCR Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,352,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,055,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계 디지털 PCR 시장에 대한 종합적인 보고서를 발표했습니다. 이 조사 보고서는 홍보 요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 상세하게 평가하고 시장 구조에 대한 통찰력을 제공합니다. 이 조사 보고서는 2024년부터 2033년까지 디지털 PCR 시장 예측 성장 궤도를 개략적으로 보여주는 독점 데이터와 통계를 게재합니다.

주요 인사이트

• 시장 규모(2024년) : 1억 8,380만 달러
• 예측 시장 매출(2033년) : 4억 380만 달러
• 세계 시장 성장률(CAGR(2024-2033년)) : 9.1%

디지털 PCR 시장 - 보고 범위:

디지털 PCR은 종양학, 감염, 유전자 검사 등 다양한 용도에서 매우 중요한 역할을 합니다. 이 기술은 핵산 검출에 탁월한 감도와 정확성을 제공하여 연구 및 임상 진단에서 정확한 정량과 분석을 가능하게 합니다. 디지털 PCR 시장은 연구실, 제약 회사, 진단센터, 학술 기관에 서비스를 제공하고 다양한 디지털 PCR 플랫폼과 소모품을 제공합니다.

시장 성장 촉진요인:

세계 디지털 PCR 시장은 고정밀 분자진단에 대한 수요 증가, 만성 질환의 유병률 증가, 분석의 민감도 및 특이성을 높이는 디지털 PCR 기술의 발전 등 여러 요인에 의해 촉진되고 있습니다. 개인화된 의료 접근법의 채택 확대, 액체 생체생성 및 희귀 대립유전자 검출에서의 용도 확대는 시장 확대를 더욱 뒷받침합니다. 게다가, 분산 검사 및 POC(Point of Care) 진단으로의 전환은 시장 성장 기회를 가속화합니다.

시장 성장 억제요인:

유망한 성장 전망에도 불구하고 디지털 PCR 시장은 높은 장비 비용, 복잡한 분석 개발 요구 사항, 진단 검사를 관리하는 규정의 복잡성과 관련된 과제에 직면하고 있습니다. 분석 성능의 편차와 데이터 분석을 위한 숙련자의 필요성은 특히 자원이 제한된 환경에서 시장 침투의 추가 장벽이 됩니다. 이러한 문제를 해결하기 위해서는 분석 설계의 지속적인 혁신, 비용 효율적인 플랫폼 개발 및 규제 경로를 간소화하기 위한 전략적 제휴가 필요합니다.

시장 기회:

디지털 PCR 시장은 기술 혁신, 건강 관리 지출 증가, 개인화 진단 솔루션에 대한 환자 수요 증가로 큰 성장 기회를 제공합니다. 디지털 PCR 플랫폼에서 인공지능과 머신러닝의 통합은 데이터 분석 능력을 강화하고 진단 정확도를 향상시킵니다. 또한 비침습적 산전 검사, 감염증 모니터링, 암 바이오마커 분석에의 응용 확대가 시장 전망을 넓혀가고 있습니다. 전략적 파트너십, R&D 투자, 신흥국 시장에 대한 지리적 확대는 진화할 기회를 활용하고 경쟁 우위를 유지하는 데 매우 중요합니다.

이 보고서에서 다루는 주요 질문

• 세계 디지털 PCR 시장의 성장을 가속하는 주요 요인은 무엇인가?
• 디지털 PCR 기술의 채용을 촉진하는 용도와 최종 사용자 분야는?
• 기술의 진보는 디지털 PCR 시장 경쟁 구도를 어떻게 바꾸고 있는가?
• 디지털 PCR 시장에 기여하는 주요 기업은 어디에서 시장의 리더십을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 디지털 PCR 시장의 새로운 동향과 미래성은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/ 분류
• 시장의 정의/ 범위/ 제한
• 포함 사항· 제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/ 개발 동향

제4장 주요 성공 요인

• 제품 채용 분석
• 신제품 출시 및 승인
• 규제 시나리오
• 주요 프로모션 전략 : 제조업체별
• 최근 제품 출시
• PESTEL 분석
• Porter's Five Forces 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID19 위기 분석

• 2024년 시장 시나리오
• COVID-19와 영향 분석
  • 제품별
  • 최종 사용자별
  • 용도별
  • 지역별

제7장 세계 디지털 PCR 시장 수요(수량) 분석

• 과거 시장(수량) 분석(2019-2023년)
• 현재 및 미래 시장(수량) 예측(2024-2033년)
  • 전년대비 성장 동향 분석

제8장 세계 디지털 PCR 시장 - 가격 분석

• 지역별 가격 분석 : 제품별
• 세계 평균 가격 분석 벤치마크
• 가격 설정의 전제조건

제9장 세계 디지털 PCR 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 매출(백만 달러) 분석(2019-2023년)
• 현재 및 미래 시장 매출(백만 달러) 예측(2024-2033년)
  • 전년대비 성장 동향 분석
  • 절대액의 기회 분석

제10장 세계 디지털 PCR 시장 분석 : 제품별

• 소개/ 주요 조사 결과
• 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 제품별(2019-2023년)
• 현재 및 미래 시장 규모(백만 달러)와 수량(유닛)의 분석과 예측 : 제품별(2024-2033년)
  • 기기
  • 소모품
  • 서비스
• 시장 매력도 분석 : 제품별

제11장 세계 디지털 PCR 시장 분석 : 용도별

• 소개/ 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 용도별(2019-2023년)
• 현재 및 미래 시장 규모(백만 달러)의 분석과 예측 : 용도별(2024-2033년)
  • 임상 진단
  • 기초조사
  • 응용조사
  • 법의학 검사
• 시장 매력도 분석 : 용도별

제12장 세계 디지털 PCR 시장 분석 : 최종 사용자별

• 소개/ 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 최종 사용자별(2019-2023년)
• 현재 및 미래 시장 규모(백만 달러)의 분석과 예측 : 최종 사용자별(2024-2033년)
  • 제약회사
  • 조사기관
  • 법의학 연구소
  • 농업기업
• 시장 매력도 분석 : 최종 사용자별

제13장 세계 디지털 PCR 시장 분석 : 지역별

• 소개
• 과거 시장 규모(백만 달러)와 수량(단위) 분석 : 지역별(2019-2023년)
• 현재 및 미래 시장 규모(백만 미 달러)와 수량(유닛)의 분석과 예측 :지역별(2024-2033년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장 매력도 분석 :지역별

제14장 북미의 디지털 PCR 시장 분석

제15장 라틴아메리카의 디지털 PCR 시장 분석

제16장 유럽 디지털 PCR 시장 분석

제17장 남아시아의 디지털 PCR 시장 분석

제18장 동아시아의 디지털 PCR 시장 분석

제19장 오세아니아의 디지털 PCR 시장 분석

제20장 중동 및 아프리카(MEA)의 디지털 PCR 시장 분석

제21장 시장 구조 분석

• 시장 분석 : 기업 Tier별
• 주요 기업의 시장 점유율 분석
• 시장현재분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세 정보
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Fluidigm Corp.
  • Formulatrix, Inc.
  • JN Medsys.
  • STILLA TECHNOLOGIES
  • Avance Bioscience
  • Fluidgm corporation,
  • jn medsys
  • Merck KGAA
  • Precigenome LLC
  • QIAGEN NV
  • Sysmex corporation.

제23장 사용된 전제조건과 약어

제24장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Digital PCR Market. The report offers a detailed assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the digital PCR market from 2024 to 2033.

Key Insights:

• Market Size (2024E): USD 183.8 Million
• Projected Market Value (2033F): USD 403.8 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 9.1%

Digital PCR Market - Report Scope:

Digital PCR plays a pivotal role in various applications, including oncology, infectious diseases, and genetic testing. This technology offers superior sensitivity and accuracy in detecting nucleic acids, enabling precise quantification and analysis in research and clinical diagnostics. The digital PCR market serves research laboratories, pharmaceutical companies, diagnostic centers, and academic institutions, offering a range of digital PCR platforms and consumables.

Market Growth Drivers:

The global digital PCR market is driven by several factors, including increasing demand for high precision molecular diagnostics, rising prevalence of chronic diseases, and advancements in digital PCR technology enhancing assay sensitivity and specificity. Growing adoption of personalized medicine approaches and expanding applications in liquid biopsy and rare allele detection further bolster market expansion. Additionally, the shift towards decentralized testing and point-of-care diagnostics accelerates market growth opportunities.

Market Restraints:

Despite promising growth prospects, the digital PCR market faces challenges related to high instrument costs, complex assay development requirements, and regulatory complexities governing diagnostic tests. Variability in assay performance and the need for skilled personnel for data analysis pose additional barriers to market penetration, particularly in resource-limited settings. Addressing these challenges requires continuous innovation in assay design, cost-effective platform development, and strategic collaborations to streamline regulatory pathways.

Market Opportunities:

The digital PCR market presents significant growth opportunities driven by technological innovations, increasing healthcare expenditure, and rising patient demand for personalized diagnostic solutions. Integration of artificial intelligence and machine learning in digital PCR platforms enhances data analysis capabilities and improves diagnostic accuracy. Moreover, expanding applications in non-invasive prenatal testing, infectious disease monitoring, and cancer biomarker analysis broaden market prospects. Strategic partnerships, investment in research and development, and geographic expansion into emerging markets are crucial for capitalizing on evolving opportunities and sustaining competitive advantage.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global digital PCR market?
• Which applications and end-user segments are propelling adoption of digital PCR technologies?
• How are technological advancements reshaping the competitive landscape of the digital PCR market?
• Who are the key players contributing to the digital PCR market, and what strategies are they employing to maintain market leadership?
• What are the emerging trends and future prospects in the global digital PCR market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital PCR market, including major companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and jn medsys, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest significantly in R&D to develop next-generation digital PCR platforms, expand assay portfolios, and enhance automation capabilities. Collaborations with clinical laboratories, biopharmaceutical firms, and regulatory agencies facilitate market access and drive technology adoption. Moreover, emphasis on clinical validation studies, regulatory compliance, and customer education promotes market growth and enhances diagnostic accuracy in the rapidly evolving digital PCR landscape.

Key Companies Profiled:

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Fluidigm Corp.
• Formulatrix, Inc.
• JN Medsys.
• STILLA TECHNOLOGIES
• Avance Bioscience
• Fluidgm corporation,
• jn medsys
• Merck KGAA
• Precigenome LLC
• QIAGEN N.V
• Sysmex corporation

Key Segments of the Digital PCR Industry

By Product:

• Instrument
• Consumables
• Services

By End User:

• Pharmaceutical Companies
• Research Institutes
• Forensic Labs
• Agriculture Companies

By Application:

• Clinical Diagnostics
• Basic Research
• Applied Research
• Forensic Testing

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. New Product Launches and Approvals
• 4.3. Regulatory Scenario
• 4.4. Key Promotional Strategies by Manufacturers
• 4.5. Recent Product Launches
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Global PCR Market Analysis
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Technology Advancements in diagnostic imaging
  • 5.2.3. New Product Launches
  • 5.2.4. Growing Geriatric Population
  • 5.2.5. Increasing minimally invasive procedures
  • 5.2.6. Increased Funding and Support from the Government
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Application
  • 6.2.4. By Region

7. Global Digital PCR Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market (Volume) Analysis, 2019-2023
• 7.2. Current and Future Market (Volume) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Digital PCR Market - Pricing Analysis

• 8.1. Regional Pricing Analysis, By Product
• 8.2. Global Average Pricing Analysis Benchmark
• 8.3. Pricing Assumptions

9. Global Digital PCR Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
  • 10.3.1. Instrument
  • 10.3.2. Consumables
  • 10.3.3. Services
• 10.4. Market Attractiveness Analysis, By Product

11. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2033
  • 11.3.1. Clinical Diagnostics
  • 11.3.2. Basic Research
  • 11.3.3. Applied Research
  • 11.3.4. Forensic Testing
• 11.4. Market Attractiveness Analysis, By Application

12. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 12.3.1. Pharmaceutical Companies
  • 12.3.2. Research Institutes
  • 12.3.3. Forensic Labs
  • 12.3.4. Agriculture Companies
• 12.4. Market Attractiveness Analysis, By End User

13. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis, By Region

14. North America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By End User
  • 14.3.4. By Application
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
  • 14.4.4. By Application
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Market Trends
• 14.8. Country-Level Analysis & Forecast
  • 14.8.1. U.S. Digital PCR Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
      • 14.8.1.2.3. By Application
  • 14.8.2. Canada Digital PCR Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
      • 14.8.2.2.3. By Application

15. Latin America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By End User
  • 15.3.4. By Application
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
  • 15.4.4. By Application
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Market Trends
• 15.8. Country-Level Analysis & Forecast
  • 15.8.1. Mexico Digital PCR Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
      • 15.8.1.2.3. By Application
  • 15.8.2. Brazil Surgical Imaging Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
      • 15.8.2.2.3. By Application
  • 15.8.3. Argentina Digital PCR Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User
      • 15.8.3.2.3. By Application

16. Europe Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. U.K.
    • 16.3.1.2. Germany
    • 16.3.1.3. Italy
    • 16.3.1.4. France
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. BENELUX
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By End User
  • 16.3.4. By Application
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
  • 16.4.4. By Application
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Market Trends
• 16.8. Country-Level Analysis & Forecast
  • 16.8.1. U.K. Digital PCR Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
      • 16.8.1.2.3. By Application
  • 16.8.2. Germany Digital PCR Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User
      • 16.8.2.2.3. By Application
  • 16.8.3. Italy Digital PCR Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By End User
      • 16.8.3.2.3. By Application
  • 16.8.4. France Digital PCR Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By End User
      • 16.8.4.2.3. By Application
  • 16.8.5. Spain Digital PCR Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By End User
      • 16.8.5.2.3. By Application
  • 16.8.6. Russia Digital PCR Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By End User
      • 16.8.6.2.3. By Application
  • 16.8.7. BENULUX Digital PCR Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By End User
      • 16.8.7.2.3. By Application

17. South Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By End User
  • 17.3.4. By Application
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
  • 17.4.4. By Application
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Market Trends
• 17.8. Country-Level Analysis & Forecast
  • 17.8.1. India Digital PCR Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
      • 17.8.1.2.3. By Application
  • 17.8.2. Indonesia Digital PCR Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
      • 17.8.2.2.3. By Application
  • 17.8.3. Malaysia Digital PCR Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User
      • 17.8.3.2.3. By Application
  • 17.8.4. Thailand Digital PCR Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By End User
      • 17.8.4.2.3. By Application

18. East Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product
  • 18.3.3. By End User
  • 18.3.4. By Application
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By End User
  • 18.4.4. By Application
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Market Trends
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. China Digital PCR Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By End User
      • 18.8.1.2.3. By Application
  • 18.8.2. Japan Digital PCR Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By End User
      • 18.8.2.2.3. By Application
  • 18.8.3. South Korea Digital PCR Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By End User
      • 18.8.3.2.3. By Application

19. Oceania Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By End User
  • 19.3.4. By Application
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By End User
  • 19.4.4. By Application
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Market Trends
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Digital PCR Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By End User
      • 19.8.1.2.3. By Application
  • 19.8.2. New Zealand Digital PCR Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By End User
      • 19.8.2.2.3. By Application

20. Middle East and Africa (MEA) Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. South Africa
    • 20.3.1.4. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By End User
  • 20.3.4. By Application
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By End User
  • 20.4.4. By Application
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Key Market Trends
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Digital PCR Market
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By End User
      • 20.8.1.2.3. By Application
  • 20.8.2. Turkey Digital PCR Market
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By End User
      • 20.8.2.2.3. By Application
  • 20.8.3. South Africa Digital PCR Market
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By End User
      • 20.8.3.2.3. By Application
  • 20.8.4. North Africa Digital PCR Market
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By End User
      • 20.8.4.2.3. By Application

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis
  • 21.3.1. Regional footprint of Players
  • 21.3.2. Product footprint by Players
  • 21.3.3. Channel footprint by Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Bio-Rad Laboratories, Inc.
    • 22.3.1.1. Company Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Marketing Strategy
      • 22.3.1.7.2. Product Strategy
      • 22.3.1.7.3. Channel Strategy
  • 22.3.2. Thermo Fisher Scientific Inc.
    • 22.3.2.1. Company Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Marketing Strategy
      • 22.3.2.7.2. Product Strategy
      • 22.3.2.7.3. Channel Strategy
  • 22.3.3. Fluidigm Corp.
    • 22.3.3.1. Company Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Marketing Strategy
      • 22.3.3.7.2. Product Strategy
      • 22.3.3.7.3. Channel Strategy
  • 22.3.4. Formulatrix, Inc.
    • 22.3.4.1. Company Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Marketing Strategy
      • 22.3.4.7.2. Product Strategy
      • 22.3.4.7.3. Channel Strategy
  • 22.3.5. JN Medsys.
    • 22.3.5.1. Company Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Marketing Strategy
      • 22.3.5.7.2. Product Strategy
      • 22.3.5.7.3. Channel Strategy
  • 22.3.6. STILLA TECHNOLOGIES
    • 22.3.6.1. Company Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Marketing Strategy
      • 22.3.6.7.2. Product Strategy
      • 22.3.6.7.3. Channel Strategy
  • 22.3.7. Avance Bioscience
    • 22.3.7.1. Company Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Key Financials
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Marketing Strategy
      • 22.3.7.7.2. Product Strategy
      • 22.3.7.7.3. Channel Strategy
  • 22.3.8. Fluidgm corporation,
    • 22.3.8.1. Company Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Key Financials
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Marketing Strategy
      • 22.3.8.7.2. Product Strategy
      • 22.3.8.7.3. Channel Strategy
  • 22.3.9. jn medsys
    • 22.3.9.1. Company Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Key Financials
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Marketing Strategy
      • 22.3.9.7.2. Product Strategy
      • 22.3.9.7.3. Channel Strategy
  • 22.3.10. Merck KGAA
    • 22.3.10.1. Company Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Key Financials
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Marketing Strategy
      • 22.3.10.7.2. Product Strategy
      • 22.3.10.7.3. Channel Strategy
  • 22.3.11. Precigenome LLC
    • 22.3.11.1. Company Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Sales Footprint
    • 22.3.11.4. Key Financials
    • 22.3.11.5. SWOT Analysis
    • 22.3.11.6. Key Developments
    • 22.3.11.7. Strategy Overview
      • 22.3.11.7.1. Marketing Strategy
      • 22.3.11.7.2. Product Strategy
      • 22.3.11.7.3. Channel Strategy
  • 22.3.12. QIAGEN N.V
    • 22.3.12.1. Company Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Sales Footprint
    • 22.3.12.4. Key Financials
    • 22.3.12.5. SWOT Analysis
    • 22.3.12.6. Key Developments
    • 22.3.12.7. Strategy Overview
      • 22.3.12.7.1. Marketing Strategy
      • 22.3.12.7.2. Product Strategy
      • 22.3.12.7.3. Channel Strategy
  • 22.3.13. Sysmex corporation.
    • 22.3.13.1. Company Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Sales Footprint
    • 22.3.13.4. Key Financials
    • 22.3.13.5. SWOT Analysis
    • 22.3.13.6. Key Developments
    • 22.3.13.7. Strategy Overview
      • 22.3.13.7.1. Marketing Strategy
      • 22.3.13.7.2. Product Strategy
      • 22.3.13.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료